Molecular Targeting Technologies Inc. (MTTI) and Evergreen Theragnostics Inc., have entered an agreement in which Evergreen will manufacture MTTI's EvaThera platform of radiopharmaceuticals.
Precirix NV, a clinical-stage biotechnology company developing novel radiopharmaceuticals in oncology, and Evergreen Theragnostics, a radiopharmaceutical contract manufacturer, have entered into an agreement whereby Evergreen will provide U.S.-based ...
Precirix NV and Evergreen Theragnostics Inc. have entered into an agreement whereby Evergreen will provide US-based manufacturing for Precirix's lead product candidate, CAM-H2.